Botulinum Neurotoxin for Chronic Pelvic Pain
This study is looking into a new way to treat chronic pelvic pain (CPP) that comes from overactive pelvic floor muscles. Researchers are testing a special medical device that uses high-density surface electromyography (a way to measure muscle activity) to guide injections of Botulinum Neurotoxin. This toxin helps relax muscles. The goal is to see if guiding the injection precisely can lead to better results compared to standard injection methods. You might be able to join if you are a woman between 18 and 60 years old, have been diagnosed with interstitial cystitis/bladder pain syndrome (IC/BPS), and have experienced pelvic pain for at least six months. The study will measure changes in your pelvic muscle activity at one and three months after the injection. The study is currently recruiting 46 participants, but its overall status is unclear.
- Study design
- This interventional study plans to enroll 46 women. It compares a standard Botulinum Neurotoxin injection to one guided by a new medical device.
- What's involved
- You would receive an injection of Botulinum Neurotoxin. Your pelvic muscle activity will be measured at the start of the study, and then again one and three months after the injection.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pelvic muscle activity will be measured at one and three months after the injection.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMGBaseline
The pelvic floor hypertonicity will be assessed by evaluating the amplitudes of intra-vaginal high-density surface electromyography recordings.
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMG1-Month Post Injection
The pelvic floor hypertonicity will be assessed by evaluating the amplitudes of intra-vaginal high-density surface electromyography recordings.
- Hypertonic metrics of the pelvic muscles defined by intra-vaginal surface EMG3-Months Post Injection
The pelvic floor hypertonicity will be assessed by evaluating the amplitudes of intra-vaginal high-density surface electromyography recordings.